How to transfer my Mounjaro prescription to New York

If you’ve been considering medications like Wegovy, Ozempic, or Mounjaro for weight loss, you’ve probably wondered: Can I get these prescribed through telehealth, or do I need to see a doctor in person?

The short answer is yes—in most cases, you can legally access GLP-1 weight loss medications through telehealth across the United States. But the details matter, and understanding your state’s specific rules can save you time, frustration, and ensure you’re getting safe, compliant care.

This comprehensive guide breaks down everything you need to know about telehealth prescribing for weight loss medications in 2025, including federal regulations, state-by-state requirements, and what to expect from your virtual visit.

Understanding the Federal Framework: Why Telehealth Works for GLP-1 Medications

At the federal level, prescribing weight loss medications like Wegovy (semaglutide) and Mounjaro (tirzepatide) via telehealth is fully legal and unrestricted. Here’s why:

The Ryan Haight Act Doesn’t Apply to GLP-1s

The Ryan Haight Act—a federal law designed to prevent online ‘pill mills’—requires an in-person medical examination before prescribing controlled substances via telemedicine. However, GLP-1 agonist medications are not controlled substances. They’re unscheduled prescription medications, which means:

• No DEA registration is required to prescribe them
• No special in-person exam is mandated by federal law
• Telehealth providers can prescribe them after establishing a valid patient-provider relationship online

This distinction is crucial. While you may have heard about temporary COVID-era telehealth flexibilities for medications like Adderall (which are controlled), those rules don’t affect GLP-1 weight loss drugs—they’ve been telehealth-friendly all along.

What ‘Valid Patient-Provider Relationship’ Means

Federal regulations and state medical boards require that prescribers establish an appropriate clinical relationship before writing any prescription. For telehealth, this typically means:

• A live video consultation (not just a text questionnaire)
• Comprehensive medical history review
• Discussion of risks, benefits, and alternatives
• Ongoing monitoring and follow-up care

Reputable telehealth platforms like Klarity Health build these safeguards into every consultation, ensuring you receive the same standard of care you’d expect in a traditional office visit—just more conveniently.

Free consultations available with select providers only.

Get a free consultation

And find an affordable, caring specialist.

Find a provider

Free consultations available with select providers only.

State-by-State Telehealth Rules: What You Need to Know

While federal law permits telehealth prescribing of GLP-1 medications, individual states can impose additional requirements. Some states have embraced telehealth with minimal restrictions, while others require in-person components to your care.

States with No In-Person Requirement

The following states allow you to receive GLP-1 weight loss medications entirely through telehealth, with no mandated in-person visits:

Full Telehealth Access States:

• California
• Connecticut
• Illinois
• New York
• Pennsylvania
• Washington

In these states, your provider can conduct a comprehensive evaluation via video visit, prescribe appropriate medication, and manage your treatment through virtual follow-ups—all without requiring you to visit a physical clinic.

States Requiring an Initial In-Person Exam

Several states mandate that patients undergo an in-person physical examination before (or shortly after) starting weight loss medication treatment:

Initial In-Person Requirement States:

• Arkansas
• Delaware
• Georgia
• Mississippi
• New Jersey
• North Dakota
• South Carolina
• Texas
• Utah

What this means for you: If you live in one of these states, you’ll typically need to:

1. Complete an initial telehealth consultation to determine if you’re a candidate
2. Visit a local healthcare provider for a physical exam (can often be your primary care doctor)
3. Return to telehealth for prescription and ongoing management

Some telehealth platforms, including Klarity Health, can help coordinate the in-person component while managing the rest of your care virtually, making the process as seamless as possible.

States with Special Clinical Requirements

A few states go beyond just requiring an exam—they mandate specific clinical protocols for prescribing weight loss medications:

Florida

• Must have BMI ≥30 (or ≥27 with comorbidities)
• Requires follow-up visits at least every 3 months
• Telehealth is allowed, but strict monitoring protocols apply

New Jersey

• Comprehensive initial evaluation required (history, physical, laboratory work)
• Must document psychological screening
• Detailed informed consent about risks required
• Treatment plan must include diet and exercise components

Virginia

• Initial physical exam and laboratory tests required
• Must include personalized diet and exercise plan
• Follow-up within 30 days of starting medication is mandatory
• Ongoing monitoring every 2-3 months

Connecticut

• Must include behavioral counseling as part of treatment
• Diet and exercise plan required alongside medication

These requirements reflect a higher standard of care but don’t prohibit telehealth—they just ensure your virtual provider is delivering comprehensive treatment.

Who Can Prescribe Weight Loss Medications via Telehealth?

Understanding provider credentials helps you evaluate telehealth services and know what to expect from your consultation.

Physicians (MD/DO)

Medical doctors and doctors of osteopathic medicine can prescribe GLP-1 weight loss medications in all 50 states via telehealth (assuming they’re licensed in your state). This is the most straightforward pathway.

Nurse Practitioners (NPs)

Nurse Practitioners are increasingly providing obesity medicine care, but their authority varies significantly by state:

Independent Practice States (NPs can prescribe without physician oversight):

• California (after 3+ years experience)
• Connecticut (after 3 years collaboration)
• Delaware (after 2 years collaboration)
• New York (after 3,600 hours)
• Utah
• Virginia (after 2 years)
• Washington

Collaborative Practice States (NPs can prescribe with physician agreement):

• Arkansas
• Florida
• Georgia (recently expanded to allow Schedule II with delegation)
• Illinois
• Mississippi
• New Jersey
• Pennsylvania
• South Carolina
• Texas (strict oversight requirements)

What this means: You may see an NP for your telehealth weight loss consultation. This is perfectly legal and appropriate—NPs are highly trained in obesity medicine and often spend more time with patients than physicians in busy practices. Klarity Health ensures all NPs work within their state’s legal framework and maintain appropriate physician collaboration where required.

Physician Assistants (PAs)

PAs can prescribe weight loss medications in all states, but like NPs, they work under physician supervision or collaboration agreements. The level of autonomy varies by state but generally mirrors NP regulations.

What Medications Can You Get via Telehealth?

Let’s look at the most commonly prescribed GLP-1 medications for weight loss and what telehealth access looks like for each:

Wegovy (Semaglutide 2.4mg)

FDA Status: Approved specifically for chronic weight management
Telehealth Prescribing: ✅ Fully available in all states (subject to state-specific rules above)
Typical Prescription: 4-week starter dose, then monthly refills up to 3 months at a time

Clinical Criteria:

• BMI ≥30, or BMI ≥27 with weight-related comorbidities (diabetes, hypertension, sleep apnea)
• Age 18+ (pediatric use 12+ requires specialist evaluation)
• No contraindications (see safety section below)

Important Note: As of May 2025, the FDA declared the Wegovy shortage resolved and banned most compounding of semaglutide. Your telehealth provider must prescribe brand-name Wegovy from a licensed pharmacy—compounded versions are no longer legally available except in rare circumstances.

Ozempic (Semaglutide 0.5-1mg)

FDA Status: Approved for Type 2 diabetes; used off-label for weight loss
Telehealth Prescribing: ✅ Available, but requires off-label documentation
Typical Prescription: Monthly supply

What ‘Off-Label’ Means:When prescribing Ozempic for weight loss, your provider must:

• Clearly document the off-label use in your medical record
• Explain that weight loss is not the FDA-approved indication
• Obtain your informed consent for off-label use
• Justify why this medication is appropriate for you

Many telehealth providers prefer to prescribe Wegovy when possible since it’s FDA-approved for obesity, but Ozempic may be used when insurance covers it preferentially or Wegovy isn’t available.

Mounjaro (Tirzepatide) / Zepbound

FDA Status: Mounjaro approved for Type 2 diabetes; Zepbound approved for weight management
Telehealth Prescribing: ✅ Fully available
Typical Prescription: 4-week titration packs

Tirzepatide is the newest option and works slightly differently than semaglutide (it targets both GLP-1 and GIP receptors). Like with Ozempic, if you’re prescribed Mounjaro for weight loss, it’s technically off-label—but Zepbound is the FDA-approved obesity version of the same medication.

The Telehealth Visit: What to Expect

Understanding the process helps you prepare and ensures you get the most from your consultation.

Step 1: Pre-Visit Questionnaire (15-20 minutes)

Before your video appointment, you’ll complete a detailed medical history including:

• Current height and weight
• Weight loss history and previous attempts
• Current medications and supplements
• Medical conditions (especially thyroid, gallbladder, pancreas issues)
• Family history (particularly thyroid cancer)
• Mental health history
• Allergies
• Lifestyle factors (diet, exercise, sleep)

Pro Tip: Have your most recent weight measurement and any relevant lab results handy. While not always required, having recent blood work (metabolic panel, A1C if diabetic, thyroid function) can help your provider make the best recommendation.

Step 2: Live Video Consultation (20-30 minutes)

During your video visit, your provider will:

Medical Evaluation:

• Review your health history in detail
• Calculate your BMI and discuss weight loss goals
• Assess whether you meet clinical criteria for medication
• Screen for contraindications
• Discuss any red flags (rapid weight changes, eating disorders, pregnancy plans)

Education and Informed Consent:

• Explain how GLP-1 medications work
• Review common side effects (nausea, digestive issues, fatigue)
• Discuss serious but rare risks (pancreatitis, gallstones, thyroid tumors)
• Set realistic expectations (typical weight loss is 10-15% of body weight over 6-12 months)
• Review the importance of lifestyle changes alongside medication

Treatment Planning:

• Create a personalized dosing schedule (usually starting low and gradually increasing)
• Discuss injection technique (these are self-administered weekly injections)
• Plan follow-up schedule
• Address your questions and concerns

Step 3: Prescription and Pharmacy Coordination

If approved, your provider will:

• Send your prescription electronically to your preferred pharmacy
• Provide injection training materials (often via video)
• Schedule your first follow-up (typically 2-4 weeks after starting)

Insurance Considerations: Klarity Health accepts both insurance and cash payment for consultations. For the medication itself, coverage varies widely:

• Some insurance plans cover Wegovy/Zepbound with prior authorization
• Ozempic/Mounjaro may be covered if you have diabetes
• Cash prices range from $900-$1,300 per month without insurance
• Patient assistance programs are available from manufacturers

Step 4: Ongoing Monitoring

Regular follow-up is essential—and required by many states. Expect:

First Month: Check-in at 2-4 weeks to assess:

• Tolerance of initial dose
• Any side effects
• Weight change
• Adherence to lifestyle modifications

Ongoing: Follow-ups every 1-3 months for:

• Dose adjustments (gradually increasing to effective dose)
• Weight and BMI tracking
• Side effect management
• Medication refills
• Periodic lab work (if needed)

Telehealth makes these follow-ups incredibly convenient—no need to take time off work or arrange childcare for a quick check-in.

Safety First: Who Should NOT Get Weight Loss Medications via Telehealth

Telehealth is convenient, but it’s not appropriate for everyone. You should not pursue GLP-1 medications (via telehealth or otherwise) if you have:

Absolute Contraindications

• Personal history of medullary thyroid carcinoma (MTC)
• Family history of Multiple Endocrine Neoplasia syndrome type 2 (MEN2)
• Current pregnancy or actively trying to conceive
• History of severe allergic reaction to semaglutide or tirzepatide

Relative Contraindications (Require Specialist Evaluation)

• History of pancreatitis
• Active gallbladder disease
• Severe gastroparesis or gastrointestinal disorders
• History of eating disorders (anorexia, bulimia)
• Severe depression with suicidal ideation
• Diabetic retinopathy (eye disease from diabetes)
• Chronic kidney disease stage 4-5

If you have any of these conditions, a telehealth provider should either decline to prescribe or refer you to a specialist for in-person evaluation. This is good medicine—any provider who dismisses these concerns is a red flag.

Special Populations

Adolescents (12-17): Wegovy is FDA-approved for teens with obesity, but most telehealth providers will not prescribe to minors—this typically requires pediatric specialist involvement.

Over 65: GLP-1s can be used in older adults, but careful evaluation of kidney function and other medications is essential.

Breastfeeding: Safety data is limited; discuss risks vs. benefits with your provider.

Red Flags: How to Spot Unsafe Telehealth Practices

The popularity of weight loss medications has unfortunately attracted some predatory practices. Protect yourself by avoiding telehealth services that:

🚩 Guarantee Prescriptions

Warning Sign: ‘Get approved in 5 minutes!’ or ‘Everyone qualifies!’

Reality: Legitimate providers will turn away patients who don’t meet clinical criteria or have contraindications. If a service guarantees you’ll get a prescription before even reviewing your medical history, run.

🚩 Skip the Video Consultation

Warning Sign: Prescription based only on a text questionnaire

Reality: Federal and state laws require a meaningful clinical interaction. Most states explicitly require live video or in-person evaluation—text-only services are likely operating illegally.

🚩 Offer Compounded or ‘Generic’ Semaglutide

Warning Sign: Advertising compounded semaglutide at lower prices

Reality: As of May 2025, the FDA banned most compounding of semaglutide. Services still offering this are operating outside FDA regulations and may be providing unsafe or ineffective products. Insist on brand-name FDA-approved medications from licensed U.S. pharmacies.

🚩 Don’t Require Follow-Up

Warning Sign: Get prescription and disappear—no follow-up care

Reality: Weight loss medication requires ongoing monitoring. Services that just ‘prescribe and forget’ are not providing safe care—and violate medical standards of practice in most states.

🚩 Lack Provider Transparency

Warning Sign: Can’t find provider credentials, state licenses, or physical address

Reality: Legitimate telehealth companies will clearly display their providers’ qualifications and state medical licenses. If you can’t verify your provider is licensed in your state, the service is operating illegally.

✅ What Good Looks Like

Klarity Health exemplifies best practices in telehealth weight loss care:

• Licensed providers in your state (MD, DO, or NP as appropriate)
• Thorough video consultations
• Clear informed consent process
• Required follow-up appointments
• Only FDA-approved, brand-name medications from licensed pharmacies
• Transparent pricing (accepts insurance AND cash pay)
• Available providers across multiple states

The Cost Question: What Will You Pay?

Telehealth cost transparency is important. Here’s what to expect:

Consultation Fees

Initial Visit: $99-$299 (Klarity Health: accepts insurance with typical copays, or cash starting at competitive rates)
Follow-Up Visits: $49-$150

Medication Costs (Monthly)

With Insurance:

• Some plans cover with prior authorization: $0-$50 copay
• Many plans don’t cover weight loss medications: full cash price

Without Insurance (Cash/GoodRx):

• Wegovy: $900-$1,300/month
• Ozempic: $900-$1,000/month
• Mounjaro/Zepbound: $900-$1,300/month

Patient Assistance Programs:

• Novo Nordisk (Wegovy/Ozempic): Savings cards may reduce cost to $25/month for eligible patients
• Eli Lilly (Mounjaro/Zepbound): Savings programs available

Total First-Year Investment

Be realistic about costs:

• Best case (good insurance): $500-$1,500 for year one
• Typical case (some coverage): $3,000-$6,000 for year one
• Cash pay: $10,000-$15,000 for year one

While this seems expensive, consider:

• You’re treating a chronic medical condition (obesity)
• Cost of obesity-related health complications (diabetes, heart disease) far exceeds medication cost
• Weight loss medications typically show ROI through reduced other healthcare needs

Klarity Health’s transparent pricing model—accepting both insurance and cash—helps make care accessible regardless of your coverage situation.

How Klarity Health Makes Telehealth Weight Loss Simple

At Klarity Health, we’ve designed our weight loss program around the real challenges patients face:

Nationwide Provider Access

We maintain a network of licensed providers across most states, so whether you’re in California, Texas, New York, or Florida, we can connect you with a qualified clinician who knows your state’s requirements.

Compliance with State Laws

Our platform automatically ensures compliance:

• In states requiring in-person exams, we’ll coordinate with local providers
• In states with follow-up requirements, we build those into your care plan
• All prescriptions meet state-specific protocols

Insurance and Cash Pay Options

Unlike many telehealth startups, Klarity accepts insurance—reducing your out-of-pocket costs significantly if you have coverage. No insurance? Our cash prices are competitive and transparent (no surprise bills).

Comprehensive Care, Not Just Prescriptions

Weight loss medication works best alongside lifestyle changes. Your Klarity provider will:

• Help you set realistic goals
• Provide nutritional guidance
• Discuss exercise strategies
• Address emotional eating and behavioral factors
• Monitor for complications
• Adjust treatment as needed

Same-Week Appointments

Most patients get an appointment within 48-72 hours—crucial when you’re motivated to start and don’t want to lose momentum waiting weeks for an office visit.

Frequently Asked Questions

Can I get weight loss medication if I only want to lose 10-15 pounds?

Probably not—and that’s actually good medicine. GLP-1 medications are FDA-approved for patients with clinical obesity (BMI ≥30) or overweight with comorbidities (BMI ≥27 plus diabetes, hypertension, etc.). If you’re only mildly overweight, your provider should recommend lifestyle modifications first. These are powerful medications with real side effects—using them for cosmetic weight loss isn’t appropriate.

Do I need to stop the medication once I reach my goal weight?

GLP-1 medications treat obesity as a chronic condition. Clinical trials show that most patients regain weight if they stop the medication. Many patients stay on a maintenance dose indefinitely. Your provider will help you determine the right long-term plan—some patients can transition to lower doses, while others need ongoing treatment.

Can I switch between telehealth and in-person care?

Absolutely. Many patients start with telehealth for convenience, then transfer to local care—or vice versa. Your Klarity Health records can be shared with any provider. Some patients use a hybrid approach: in-person visits for annual physicals, telehealth for routine medication management.

What if I move to a different state?

Your provider must be licensed in the state where you’re physically located during the telehealth visit. If you move, you may need to transition to a different provider in our network licensed in your new state. Klarity Health operates across many states, making this transition relatively seamless.

How long will I wait to get my first prescription?

After your video consultation (typically scheduled within 2-3 days), approved prescriptions are sent electronically to your pharmacy within hours. Depending on the pharmacy and insurance, you can usually pick up medication within 1-3 business days. Some medications may require prior authorization from insurance, which can add 3-7 days.

Are online weight loss clinics legal?

Yes—when operated correctly. Legal telehealth weight loss care requires:

• Provider licensed in your state
• Appropriate clinical evaluation (usually video visit)
• Compliance with state-specific prescribing rules
• Use of FDA-approved medications from licensed pharmacies
• Ongoing monitoring and follow-up

Services that cut corners on any of these requirements are operating in legal gray areas or outright illegally.

The Bottom Line: Is Telehealth Right for Your Weight Loss Journey?

Telehealth access to GLP-1 weight loss medications represents a genuine breakthrough in obesity medicine. For many patients—especially those in rural areas, with busy schedules, or who struggle with the stigma of in-person weight loss visits—virtual care removes barriers that have kept effective treatment out of reach.

Telehealth is a great fit if you:

• Meet clinical criteria for medication (BMI ≥30 or ≥27 with comorbidities)
• Are comfortable with video consultations
• Can commit to regular follow-up
• Are willing to make lifestyle changes alongside medication
• Live in a state with favorable telehealth rules (or can accommodate in-person requirements)

Consider traditional in-person care if you:

• Have complex medical conditions requiring hands-on evaluation
• Prefer face-to-face interactions
• Have a great relationship with a local provider already
• Need extensive support services not available via telehealth

For most people, the answer isn’t either/or—it’s both. Hybrid care that combines telehealth convenience for routine management with occasional in-person visits for comprehensive evaluation offers the best of both worlds.

Take the Next Step with Klarity Health

If you’re ready to explore whether weight loss medication is right for you, Klarity Health makes it simple to get started:

1. Complete a brief online assessment – takes 10 minutes
2. Schedule your video consultation – usually within 48 hours
3. Meet with a licensed provider – comprehensive evaluation via video
4. Get your prescription (if appropriate) – sent to your pharmacy the same day
5. Start your journey – with ongoing support every step of the way

We’re in-network with major insurance plans and offer transparent cash pricing for those without coverage. Same-week appointments available in most states.

Ready to take control of your weight and health? Schedule your consultation with Klarity Health today and discover how telehealth can make weight loss medication accessible, affordable, and effective.

Disclaimer: This article is for informational purposes only and does not constitute medical advice. Eligibility for weight loss medication depends on individual medical evaluation. Not all patients will be approved for treatment. Klarity Health providers make prescribing decisions based on clinical appropriateness and state regulations.

References and Sources

1. Drug Enforcement Administration (DEA). (November 15, 2024). ‘DEA and HHS Extend Telemedicine Flexibilities through 2025.’ Retrieved from www.dea.gov

2. Axios News. (November 18, 2024). ‘COVID-era telehealth prescribing extended for controlled substances.’ Retrieved from www.axios.com

3. McDermott Will & Emery. (November 18, 2024). ‘DEA Extends Telemedicine Flexibilities for Controlled Substance Prescribing Through December 31, 2025.’ Retrieved from www.mwe.com

4. Goodwin Procter LLP. (March 27, 2024). ‘The Changing Regulatory and Reimbursement Landscape for Weight Loss Drugs.’ Retrieved from www.goodwinlaw.com

5. Reuters. (May 30, 2025). ‘Hims & Hers cuts 4% of workforce amid ban on weight-loss drug copies.’ Retrieved from www.reuters.com

📅 RESEARCH CURRENCY STATEMENT
Verified as of: December 17, 2025
DEA Rules Status: DEA’s COVID-era telehealth flexibilities remain in effect through December 31, 2025. Non-controlled medications (like GLP-1 agonists) are not subject to the Ryan Haight Act’s in-person rule, so they can be prescribed via telehealth under federal law.
States Verified: AR, CA, CT, DE, FL, GA, IL, MS, NJ, NY, ND, PA, SC, TX, UT, VA, WA (as of Dec 2025)
Sources newer than 2024: 15 of 18 sources (most sources are 2024–2025; older sources used only for baseline context)

Source:

• https://www.axios.com/2024/11/18/covid-telehealth-prescribing-extended-adderall#:~:text=The%20Drug%20Enforcement%20Administration%20,year%20extension
• https://www.dea.gov/documents/2024/2024-11/2024-11-15/dea-and-hhs-extend-telemedicine-flexibilities-through-2025#:~:text=telemedicine%20flexibilities%20through%20December%2031%2C,HHS%20on%20November%2015%2C%202024
• https://www.mwe.com/insights/dea-signals-extension-of-telemedicine-flexibilities-for-controlled-substance-prescribing-for-2026/#:~:text=A%20new%20rule%20posted%20on,date%20of%20December%2031%2C%202025
• https://www.mwe.com/insights/dea-extends-telemedicine-flexibilities-for-controlled-substance-prescribing-through-december-31-2025/#:~:text=,a%20final%20set%20of%20regulations
• https://www.mwe.com/insights/dea-extends-telemedicine-flexibilities-for-controlled-substance-prescribing-through-december-31-2025/#:~:text=31%2C%202024.%20,In%20February%202023%2C%20the%20DEA
• https://www.mwe.com/insights/dea-extends-telemedicine-flexibilities-for-controlled-substance-prescribing-through-december-31-2025/#:~:text=to%20perform%20an%20in,rule%20regarding%20telemedicine%20prescribing%20of
• https://www.whitehouse.senate.gov/news/release/whitehouse-murkowski-warner-blackburn-urge-white-house-and-dea-to-extend-telehealth-flexibilities-for-substance-use-disorder-and-mental-health-treatment/#:~:text=Whitehouse%2C%20Murkowski%2C%20Warner%2C%20Blackburn%20Urge,substance%20use%20disorder%20treatment%20Washington
• https://natlawreview.com/article/arkansas-it-again-telemedicine-regulation-arkansas-undergoes-additional-change#:~:text=Arkansas%20currently%20has%20one%20of,person%20examination
• https://www.nextech.com/blog/semaglutide-laws-by-state#:~:text=Who%20can%20prescribe%20semaglutide%3F%20,
• https://natlawreview.com/article/arkansas-it-again-telemedicine-regulation-arkansas-undergoes-additional-change#:~:text=Arkansas%20currently%20has%20one%20of,encounter%20to%20establish%20a%20valid